Skip to Main Content

Paper Details

Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.
Ann Oncol
77
2020
MHC, T-cell, antitumour T-, cancer, cancer cells, cancer types, endogenous retroelements, gene fusions, mutated peptides, neoantigen, peptide major histocompatibility complex, tumour, tumour cells, variant allele
Author NameAffiliation
Miguel Vazquez
Rosalba Lepore
Jasreet HundalThe McDonnell Genome Institute, Washington University in St Louis
Timothy A ChanCenter for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Timothy A ChanCenter for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Malachi GriffithWashington University School of Medicine
  • 1 - 6

Datasets

Release 1.2